Options for systemic therapy include chemotherapy, immunotherapy, or hormone therapy, and the choice of treatment is largely dependent on the type of primary cancer; for example, the use of tamoxifen or aromatase inhibitors in choroidal metastases from breast cancer, as they tend to express oestrogen or progesterone receptors [1]. This evidence concerns the gene CYP19A1 and cancer.